Nextech Invest’s Tyra Biosciences TYRA Stock Holding History

Nextech Invest’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$155M	Hold	4,055,861	–	–	10.93%	2
2025 Q4	$107M	Hold	4,055,861	–	–	10.31%	2
2025 Q3	$56.7M	Hold	4,055,861	–	–	8.64%	3
2025 Q2	$38.8M	Hold	4,055,861	–	–	7.35%	3
2025 Q1	$37.7M	Hold	4,055,861	–	–	8.77%	2
2024 Q4	$56.4M	Hold	4,055,861	–	–	9.15%	2
2024 Q3	$95.4M	Hold	4,055,861	–	–	13.39%	2
2024 Q2	$64.9M	Hold	4,055,861	–	–	10.91%	2
2024 Q1	$66.5M	Buy	4,055,861 +1,537,279	+61%	+$25.2M	10.54%	3
2023 Q4	$34.9M	Hold	2,518,582	–	–	6.5%	7
2023 Q3	$34.7M	Hold	2,518,582	–	–	10.51%	3
2023 Q2	$42.9M	Hold	2,518,582	–	–	14.58%	2
2023 Q1	$40.5M	Hold	2,518,582	–	–	16.89%	2
2022 Q4	$19.1M	Hold	2,518,582	–	–	7.62%	3
2022 Q3	$22.1M	Hold	2,518,582	–	–	7.15%	4
2022 Q2	$18M	Hold	2,518,582	–	–	6.07%	5
2022 Q1	$26.9M	Hold	2,518,582	–	–	7.69%	5
2021 Q4	$35.4M	Buy	+2,518,582	New	+$50M	9.34%	4

Other funds holding TYRA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

APMC

Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Nextech Invest's TYRA Position: Q1 2026 in Review

Nextech Invest held its Tyra Biosciences (TYRA) position steady in Q1 2026 at 4,055,861 shares worth $155M. The position accounts for 10.93% of the portfolio, ranked #2.

Nextech Invest first reported a position in TYRA in Q4 2021 and has held it in 18 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

Nextech Invest held 4,055,861 shares of Tyra Biosciences worth $155M as of Q1 2026.
Nextech Invest left its Tyra Biosciences share count unchanged in Q1 2026.
Tyra Biosciences made up 10.93% of Nextech Invest's portfolio in Q1 2026, its #2 holding.
Nextech Invest first reported a position in Tyra Biosciences in Q4 2021 and has held it in 18 quarters since.
164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Nextech Invest's 13F filing for Q1 2026, filed 15 May 2026.